Reducing Stigma Through a Mental Health Art Exhibition and Its Printed Brochure
Mental health art exhibitions, as an intervention strategy integrating artistic expression and social contact, have the potential to positively impact the elimination of stigma and discrimination associated with mental health problems. Based on a two-phase experimental design, this study aims to evaluate the effect of
| Condition(s) | Mental Health Issue |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Mental health art exhibitions, as an intervention strategy integrating artistic expression and social contact, have the potential to positively impact the elimination of stigma and discrimination associated with mental health problems. Based on a two-phase experimental design, this study aims to evaluate the effect of a real-world mental health art exhibition (Phase One) and its printed brochure (Phase Two) on stigma/discrimination and related outcomes, such as mental health literacy. The evaluation will encompass three categories of people: those with lived experience of mental disorders, family members and friends of those with lived experience, and the general public. Qualitative methods, such as in-depth interviews, will also be used for the evaluation. |
| Who can participate | General Inclusion Criteria: * Adults aged 18 and above General Exclusion Criteria: * Individuals who are unable to understand the content of the questionnaire due to illness and other factors * Mental health professionals, including psychiatrists, psychologists, nurses, social workers and medical students Additional Inclusion Criteria for Phase One: * Individuals who attend the exhibition offline Additional Inclusion Criteria for Phase Two: * Individuals who did not visit the exhibition of Phase One |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Hunan University |
| Locations | Wuhan, Hubei, China; Changsha, Hunan, China; Changsha, Hunan, China |
| Start date | 2024-04-12 |
| NCT ID | NCT06366373 |
| Official listing | https://clinicaltrials.gov/study/NCT06366373 |